REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medimplant S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medimplant S.A.S. Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Medimplant S.A.S. is based in Ecuador. The head office is in Loja. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on August 25, 2020. 5 (2024) employees currently work for Medimplant S.A.S.. From the latest financial highlights, Medimplant S.A.S. reported a net sales revenue drop of 16.77% in 2024. Its’ total assets recorded a negative growth of 6.97%. Medimplant S.A.S.’s net profit margin decreased by 0.69% in 2024.

Headquarters
Calle 18 de Noviembre 207-32
Loja; Loja;

Contact Details: Purchase the Medimplant S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Medimplant S.A.S. report to view the information.
Registered Capital:
Purchase the Medimplant S.A.S. report to view the information.
Financial Auditors:
Purchase the Medimplant S.A.S. report to view the information.
Incorporation Date:
August 25, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Medimplant S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-16.77%▼
Total operating revenue
-16.79%▼
Operating profit (EBIT)
-46.97%▼
EBITDA
-48.2%▼
Net Profit (Loss) for the Period
-46.01%▼
Total Assets
-6.97%▼
Total Equity
9.07%▲
Operating Profit Margin (ROS)
-1.1%▼
Net Profit Margin
-0.69%▼
Return on Equity (ROE)
-9.12%▼
Quick Ratio
0.27%▲
Cash Ratio
0.22%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo